Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$0.85 - $1.41 $11,582 - $19,212
-13,626 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$1.16 - $2.5 $2,616 - $5,640
-2,256 Reduced 14.2%
13,626 $18,000
Q4 2021

Feb 08, 2022

BUY
$2.46 - $8.74 $39,069 - $138,808
15,882 New
15,882 $40,000
Q3 2021

Nov 12, 2021

SELL
$5.1 - $9.39 $95,115 - $175,123
-18,650 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$3.95 - $6.88 $7,769 - $13,532
1,967 Added 11.79%
18,650 $119,000
Q1 2021

May 14, 2021

BUY
$2.01 - $5.55 $33,532 - $92,590
16,683 New
16,683 $74,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $64.6M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.